The evolving role of time-limited targeted therapy in chronic lymphocytic leukemia

Expert Rev Anticancer Ther. 2020 Dec;20(12):1015-1019. doi: 10.1080/14737140.2020.1829482. Epub 2020 Oct 5.
No abstract available

Keywords: CLL; MRD; time-limited therapy; venetoclax.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Molecular Targeted Therapy*
  • Time Factors